Syntegon
Buying intent
33 tracked signals | Top 15 topics are below | Sales and Engineering are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Syntegon's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
5d ago
9d ago
20d ago
16d ago
3d ago
2d ago
5d ago
16d ago
2d ago
11d ago
16d ago
11d ago
12d ago
11d ago
20d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Syntegon
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
11 people across every department at Syntegon, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileWe are Syntegon, a leading global technology company and strategic partner to the pharmaceutical, biotech, and food industries. With a strategic focus on the growing pharmaceutical and biotech sectors, we play a vital role in global healthcare, providing in-depth process expertise and mission-critical technologies for the safe, efficient, and compliant production of essential medicines. In the f
New capability sought
Employee posts (LinkedIn)Work Anniversary
Top accounts researching Syntegon
names withheld on the public pageThese are companies whose own people brought up Syntegon unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
57,400 companies · 377,367 people are researching Career Development
Syntegon's own team shows 3 signals on this topic. No one outside Syntegon has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Pharmaceutical Manufacturing728 cos · 2,694 people
- Pharmaceuticals1,147 cos · 6,156 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 3 people; IT — 2 people; Product — 1 person; Engineering — 1 person
What's been said
public posts mentioning SyntegonUp to 9 public excerpts naming Syntegon from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
I had the pleasure of delivering an intercultural training session at Syntegon together with my colleague Sanja Welch for the students of Hochschule Heilbronn. It was an engaging and rewarding experience to work with such motivated students and discuss the importance of intercultural communication, collaboration, and global perspectives in today’s professional environment. Thankful for this opportunity and looking forward to many more meaningful experiences ahead. #InterculturalTraining #GlobalCommunication #LearningAndDevelopment #StudentEngagement #Collaboration #ProfessionalDevelopment
May 2026My Interphex journey so far. Who else is making their way to Manhattan today? Come say hi to Chad Tyler Jordan Carder Matthias Moessinger Harald Kaufmann Jerry Carlson Hartkämper Thomas in the Syntegon booth 1719
Apr 2026We have just started our PDA - Parenteral Drug Association Training Course „All about pre-filled syringes systems“ here in Munich. A 360 degree view on the topic: ▶️Syringe body Bernd Zeiß ▶️Closure systems Christa Jansen-Otten ▶️Fill & Finish Klaus Ullherr Would that be of interest for you too? Gerresheimer West Pharmaceutical Services Syntegon
Looking forward to the ISPE #EAC in Copenhagen next week! Representing the #Sustainability CoP, I’ll be presenting two sessions focused on sustainability in pharma — both practical and action-oriented — and I’d love to connect with peers working to advance sustainability in life sciences. 📚 Sustainability in Pharma: Introduction to the New Guide — with Roger Ouimet ( Agile GxP Advisors ) We’ll introduce the new ISPE Sustainability Guide and discuss how companies can build a sustainability culture, set measurable goals, and identify high-impact initiatives. We’ll point attendees to the guide and outline next steps from the Sustainability CoP’s growing body of knowledge. 💸 Successful Business Cases for Sustainability Initiatives — with Dejanira Araiza Illan, PhD ( Johnson & Johnson ) Securing leadership support means translating environmental benefits into financial and strategic value. This session will share practical guidance on building persuasive business cases (lifecycle cost, risk mitigation, regulatory alignment, stakeholder engagement), integrating circular economy principles, and real-world case studies that demonstrate ROI and implementation pathways. Case studies: waste heat utilization at FUJIFILM Biotechnologies Hillerod, contributed by Peter Skals and the #DiCE (Digital Health in the Circular Economy) initiative. If you’ll be in Copenhagen, let’s meet — I’d love to hear about your sustainability projects and share our CoP's tools and templates to help you build stronger business cases. #ISPE #Sustainability #Pharma #CircularEconomy Syntegon
Apr 2026